HEADER HYDROLASE/HYDROLASE INHIBITOR 24-AUG-99 1CVW TITLE CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR TITLE 2 VIIA (DES-GLA) COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR VIIA (LIGHT CHAIN) (DES-GLA); COMPND 3 CHAIN: L; COMPND 4 EC: 3.4.21.21; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: COAGULATION FACTOR VIIA (HEAVY CHAIN) (DES-GLA); COMPND 8 CHAIN: H; COMPND 9 EC: 3.4.21.21; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_ORGAN: OVARY; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: CHINESE HAMSTER; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 16 EXPRESSION_SYSTEM_ORGAN: OVARY KEYWDS BLOOD COAGULATION, FACTOR VIIA, SERINE PROTEASE, EGF, HYDROLASE- KEYWDS 2 HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.KEMBALL-COOK,D.J.D.JOHNSON,E.G.D.TUDDENHAM,K.HARLOS REVDAT 7 27-FEB-13 1CVW 1 HETATM HETNAM REVDAT 6 13-JUL-11 1CVW 1 VERSN REVDAT 5 24-FEB-09 1CVW 1 VERSN REVDAT 4 01-APR-03 1CVW 1 JRNL REVDAT 3 26-SEP-01 1CVW 1 HELIX REVDAT 2 02-APR-00 1CVW 1 JRNL REMARK REVDAT 1 31-AUG-99 1CVW 0 JRNL AUTH G.KEMBALL-COOK,D.J.JOHNSON,E.G.TUDDENHAM,K.HARLOS JRNL TITL CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION JRNL TITL 2 FACTOR VIIA (DES-GLA). JRNL REF J.STRUCT.BIOL. V. 127 213 1999 JRNL REFN ISSN 1047-8477 JRNL PMID 10544046 JRNL DOI 10.1006/JSBI.1999.4158 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.J.JOHNSON,P.G.NUGENT,E.G.TUDDENHAM,K.HARLOS,G.KEMBALL-COOK REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY ANALYSIS OF ACTIVE REMARK 1 TITL 2 SITE-INHIBITED HUMAN COAGULATION FACTOR VIIA (DES-GLA) REMARK 1 REF J.STRUCT.BIOL. V. 125 90 1999 REMARK 1 REFN ISSN 1047-8477 REMARK 1 DOI 10.1006/JSBI.1998.4078 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 22570 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1099 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2390 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 171 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.37 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CVW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-AUG-99. REMARK 100 THE RCSB ID CODE IS RCSB009573. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22596 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 90.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.29400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SOLUTION 30, HAMPTON SCREEN II, SEE REMARK 280 REFERENCE 1, PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.15000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.42500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.42500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.57500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.42500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.42500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 85.72500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.42500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.42500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 28.57500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.42500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.42500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 85.72500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 57.15000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE CHLOROMETHYLKETONE GROUP AND THE ADJACENT RESIDUE OF THE REMARK 400 INHIBITOR BIND WITH PROTEIN BY TWO COVALENT BONDS: 1) VIA A REMARK 400 HEMIKETAL GROUP TO OG SER H 195; 2) VIA A METHYLENE GROUP TO NE2 REMARK 400 HIS H 57. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CE1 HIS H 57 CM 0GE H 301 1.75 REMARK 500 OG SER H 195 O2 0GE H 301 1.88 REMARK 500 OG SER H 195 CM 0GE H 301 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP H 194 C SER H 195 N -0.165 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 HIS H 199 N - CA - C ANGL. DEV. = -16.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN L 100 -103.41 -121.98 REMARK 500 THR L 108 41.39 -99.33 REMARK 500 VAL L 125 -37.48 -131.28 REMARK 500 ASN H 48 -173.21 -171.41 REMARK 500 HIS H 71 -64.29 -142.62 REMARK 500 THR H 129C -64.11 -139.47 REMARK 500 GLN H 170 43.33 -84.61 REMARK 500 GLN H 170A -1.44 -150.51 REMARK 500 VAL H 170E -106.14 -99.04 REMARK 500 ASP H 189 167.43 178.29 REMARK 500 SER H 214 -62.87 -123.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA H 302 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU H 75 O REMARK 620 2 GLU H 80 OE1 88.7 REMARK 620 3 GLU H 70 OE1 166.0 105.1 REMARK 620 4 HOH H 441 O 89.0 82.7 90.5 REMARK 620 5 ASP H 72 O 82.0 167.6 84.7 105.0 REMARK 620 6 HOH H 440 O 103.7 88.2 79.3 164.2 86.2 REMARK 620 N 1 2 3 4 5 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-{[5-(DIMETHYLAMINO)NAPHTHALEN-1-YL]SULFONYL}-L- REMARK 630 ALPHA-GLUTAMYL-N-[(2S,3S)-6-CARBAMIMIDAMIDO-1-CHLORO-2- REMARK 630 HYDROXYHEXAN-3-YL]GLYCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0GE H 301 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ANS GLU GLY AR7 0QE REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0GE H 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA H 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DAN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAINS OF HUMAN REMARK 900 TISSUE FACTOR WITH ACTIVE SITE-INHIBITED COAGULATION FVIIA DBREF 1CVW L 90 144 UNP P08709 FA7_HUMAN 150 204 DBREF 1CVW H 16 257 UNP P08709 FA7_HUMAN 213 466 SEQRES 1 L 55 ILE CYS VAL ASN GLU ASN GLY GLY CYS GLU GLN TYR CYS SEQRES 2 L 55 SER ASP HIS THR GLY THR LYS ARG SER CYS ARG CYS HIS SEQRES 3 L 55 GLU GLY TYR SER LEU LEU ALA ASP GLY VAL SER CYS THR SEQRES 4 L 55 PRO THR VAL GLU TYR PRO CYS GLY LYS ILE PRO ILE LEU SEQRES 5 L 55 GLU LYS ARG SEQRES 1 H 254 ILE VAL GLY GLY LYS VAL CYS PRO LYS GLY GLU CYS PRO SEQRES 2 H 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS SEQRES 3 H 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA SEQRES 4 H 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU SEQRES 5 H 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP SEQRES 6 H 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE SEQRES 7 H 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE SEQRES 8 H 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP SEQRES 9 H 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER SEQRES 10 H 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER SEQRES 11 H 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU SEQRES 12 H 254 GLU LEU MET VAL LEU ASN VAL PRO ARG LEU MET THR GLN SEQRES 13 H 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO SEQRES 14 H 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP SEQRES 15 H 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO SEQRES 16 H 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY SEQRES 17 H 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS SEQRES 18 H 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP SEQRES 19 H 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL SEQRES 20 H 254 LEU LEU ARG ALA PRO PHE PRO HET 0GE H 301 41 HET CA H 302 1 HETNAM 0GE N-{[5-(DIMETHYLAMINO)NAPHTHALEN-1-YL]SULFONYL}-L-ALPHA- HETNAM 2 0GE GLUTAMYL-N-[(2S,3S)-6-CARBAMIMIDAMIDO-1-CHLORO-2- HETNAM 3 0GE HYDROXYHEXAN-3-YL]GLYCINAMIDE HETNAM CA CALCIUM ION HETSYN 0GE 1,5-DANSYL-GLU-GLY-ARG-CHLOROMETHYL KETONE, BOUND FORM FORMUL 3 0GE C26 H38 CL N7 O7 S FORMUL 4 CA CA 2+ FORMUL 5 HOH *171(H2 O) HELIX 1 1 ASN L 93 CYS L 98 5 6 HELIX 2 2 ILE L 138 LYS L 143 1 6 HELIX 3 3 ALA H 55 ASP H 60 5 6 HELIX 4 4 ASN H 60D ARG H 62 5 3 HELIX 5 5 GLU H 125 THR H 129C 1 8 HELIX 6 6 LEU H 129D VAL H 129G 5 4 HELIX 7 7 MET H 164 GLN H 170 1 7 HELIX 8 8 TYR H 234 ARG H 243 1 10 SHEET 1 A 2 TYR L 101 HIS L 105 0 SHEET 2 A 2 LYS L 109 ARG L 113 -1 O ARG L 113 N TYR L 101 SHEET 1 B 2 TYR L 118 LEU L 120 0 SHEET 2 B 2 CYS L 127 PRO L 129 -1 O THR L 128 N SER L 119 SHEET 1 C 8 LYS H 20 VAL H 21 0 SHEET 2 C 8 MET H 156 LEU H 163 -1 O VAL H 157 N LYS H 20 SHEET 3 C 8 MET H 180 ALA H 183 -1 O CYS H 182 N LEU H 163 SHEET 4 C 8 GLY H 226 ARG H 230 -1 O TYR H 228 N PHE H 181 SHEET 5 C 8 THR H 206 TRP H 215 -1 N TRP H 215 O VAL H 227 SHEET 6 C 8 PRO H 198 TYR H 203 -1 N THR H 201 O TYR H 208 SHEET 7 C 8 PHE H 135 GLY H 140 -1 N LEU H 137 O ALA H 200 SHEET 8 C 8 MET H 156 LEU H 163 -1 O VAL H 160 N SER H 136 SHEET 1 D 8 LEU H 251 ALA H 254 0 SHEET 2 D 8 GLN H 81 PRO H 91 1 N VAL H 88 O LEU H 252 SHEET 3 D 8 ALA H 104 LEU H 108 -1 O LEU H 105 N ILE H 89 SHEET 4 D 8 TRP H 51 SER H 54 -1 N VAL H 52 O LEU H 106 SHEET 5 D 8 ALA H 39 LEU H 46 -1 N THR H 45 O VAL H 53 SHEET 6 D 8 GLN H 30 VAL H 35 -1 N LEU H 33 O CYS H 42 SHEET 7 D 8 LEU H 64 LEU H 68 -1 O ILE H 65 N LEU H 34 SHEET 8 D 8 GLN H 81 PRO H 91 -1 O ARG H 83 N ALA H 66 SSBOND 1 CYS L 91 CYS L 102 1555 1555 2.03 SSBOND 2 CYS L 98 CYS L 112 1555 1555 2.03 SSBOND 3 CYS L 114 CYS L 127 1555 1555 2.04 SSBOND 4 CYS L 135 CYS H 122 1555 1555 2.03 SSBOND 5 CYS H 22 CYS H 27 1555 1555 2.05 SSBOND 6 CYS H 42 CYS H 58 1555 1555 2.54 SSBOND 7 CYS H 168 CYS H 182 1555 1555 2.04 SSBOND 8 CYS H 191 CYS H 220 1555 1555 2.03 LINK O GLU H 75 CA CA H 302 1555 1555 2.17 LINK OE1 GLU H 80 CA CA H 302 1555 1555 2.37 LINK OE1 GLU H 70 CA CA H 302 1555 1555 2.40 LINK CA CA H 302 O HOH H 441 1555 1555 2.40 LINK O ASP H 72 CA CA H 302 1555 1555 2.42 LINK CA CA H 302 O HOH H 440 1555 1555 2.49 LINK NE2 HIS H 57 CM 0GE H 301 1555 1555 1.41 LINK OG SER H 195 C2 0GE H 301 1555 1555 1.42 CISPEP 1 PHE H 256 PRO H 257 0 0.20 SITE 1 AC1 13 HIS H 57 PRO H 170I ASP H 189 SER H 190 SITE 2 AC1 13 LYS H 192 GLY H 193 SER H 195 SER H 214 SITE 3 AC1 13 TRP H 215 GLY H 216 GLN H 217 GLY H 219 SITE 4 AC1 13 HOH H 452 SITE 1 AC2 6 GLU H 70 ASP H 72 GLU H 75 GLU H 80 SITE 2 AC2 6 HOH H 440 HOH H 441 CRYST1 94.850 94.850 114.300 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010543 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010543 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008749 0.00000